Previous 10 | Next 10 |
Co-Diagnostics, Inc. to Present at Upcoming Technology and Health Research Conferences PR Newswire SALT LAKE CITY , June 15, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company"), a molecular diagnostics company with a unique, paten...
At the conclusion of the 2021 Russell indexes annual reconstitution following notable healthcare stocks will join the Russell 3000 Index, effective June 28 after the U.S. market opens.Bionano Genomics (BNGO), Asensus Surgical (ASXC), Ocugen (OCGN), Senseonics Holdings (SEN...
Vaccine hesitancy and new coronavirus variants are a threat to herd immunity. The alternative solution to vaccination for re-opening the economy is mass testing. Co-Diagnostics is expected to benefit from higher COVID-19 testing demand as travel resumes. A fortress-like balance sh...
Co-Diagnostics, Inc. (CODX) Q1 2021 Earnings Conference Call May 13, 2021, 04:30 PM ET Company Participants Andrew Benson - Head of IR Dwight Egan - CEO Brian Brown - CFO Conference Call Participants Yi Chen - H.C. Wainwright Theodore O'Neill - Litchfield Hills Research Presentation Operator ...
Co-Diagnostics (CODX) posts first-quarter results that beat Wall Street estimates, helped by sales of its Logix Smart COVID-19 Test.Shares up nearly 5% post-market.The company reported quarterly revenue of $20M, beating analysts' estimate by $0.11M.Gross profit increased t...
Co-Diagnostics (CODX): Q1 GAAP EPS of $0.26 beats by $0.04.Revenue of $20M beats by $0.11M.Gross profit increased to $16.8 million, representing 83.7% of consolidated revenue due to improved product mix as compared to the prior-year period.Shares +5%.Press Release For further details see: ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Since my last bearish column on Ocugen (NASDAQ: OCGN ) was published, in which I suggested that some investors short OCGN stock, the shares have flown higher. Specifically, they have more than doubled. Source: S...
Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , May 4, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the developm...
Co-Diagnostics, Inc. and Partner CRL to Discuss Saliva Testing and Future Applications of PCR in 360Dx Webinar PR Newswire SALT LAKE CITY , April 29, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics compan...
Co-Diagnostics, Inc. JV CoSara Diagnostics Recognized for Work Combating COVID-19 Surge in India Times of India article highlights CoSara's tireless efforts to increase manufacturing of COVID-19 tests in response to deadly wave of infections PR Newswire SALT LAKE C...
News, Short Squeeze, Breakout and More Instantly...
Co-Diagnostics, Inc. to Host Booth and Discuss Advancing POC/OTC Diagnostics at ADLM 2024 in Chicago PR Newswire SALT LAKE CITY , July 29, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company wi...
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Release Date and Webcast PR Newswire SALT LAKE CITY , July 25, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the developme...
Co-Diagnostics, Inc. Expands Vector Control Customer Base to 25 Customers across 15 U.S. States PR Newswire SALT LAKE CITY , July 2, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company" or "Co-Dx™"), a molecular diagnostics company w...